Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment ...

A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...

We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this ...

If you have $500, you should check out Vertex Pharmaceuticals ( VRTX 0.13%). Here's why this biotech stock is a great ...

Chronic pain affected nearly one in four U.S. adults, new CDC survey data showed. In 2023, 24.3% of adults had chronic pain ...

Recent peer-reviewed study supports what patients shared with their own voices: Automated red blood cell exchange improves the l ...

Dr. Brooke Williams’ ties to Novant Health Forsyth Medical Center go back long before she was wearing a white coat. “I was ...

What the symptoms are: Lethargy, nausea, vomiting, loss of appetite, joint pain and dark-colored urine are all common ...

Thousands of diseases — such as cystic fibrosis, sickle cell anemia and cancer — are caused when there’s a change or mutation in a gene. Most people have relatives who have or had at least one chronic ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to Fulcrum Therapeutics Third Quarter ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.